Back to Search
Start Over
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
- Source :
- CMAJ: Canadian Medical Association Journal. April 26, 2021, Vol. 193 Issue 17, pE592, 9 p.
- Publication Year :
- 2021
-
Abstract
- BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to control SARS-CoV-2 (i.e., mobility threshold), and the difference relative to the observed mobility level (i.e., mobility gap). METHODS: We conducted a time-series study of the weekly incidence of SARSCoV-2 in Canada from Mar. 15, 2020, to Mar. 6, 2021. The outcome was weekly growth rate, defined as the ratio of cases in a given week versus the previous week. We evaluated the effects of average time spent outside the home in the previous 3 weeks using a log-normal regression model, accounting for province, week and mean temperature. We calculated the SARS-CoV-2 mobility threshold and gap. RESULTS: Across the 51-week study period, a total of 888 751 people were infected with SARS-CoV-2. Each 10% increase in the mobility gap was associated with a 25% increase in the SARS-CoV-2 weekly case growth rate (ratio 1.25, 95% confidence interval 1.20-1.29). Compared to the prepandemic baseline mobility of 100%, the mobility threshold was highest in the summer (69%; interquartile range [IQR] 67%-70%), and dropped to 54% in winter 2021 (IQR 52%-55%); a mobility gap was present in Canada from July 2020 until the last week of December 2020. INTERPRETATION: Mobility strongly and consistently predicts weekly case growth, and low levels of mobility are needed to control SARS-CoV-2 through spring 2021. Mobility measures from anonymized smartphone data can be used to guide provincial and regional loosening and tightening of physical distancing measures.<br />The global toll of coronavirus disease 2019 (COVID-19) continues to grow, despite the promise of recently approved vaccines. A surge is occurring in many countries in the Northern Hemisphere, including [...]
Details
- Language :
- English
- ISSN :
- 08203946
- Volume :
- 193
- Issue :
- 17
- Database :
- Gale General OneFile
- Journal :
- CMAJ: Canadian Medical Association Journal
- Publication Type :
- Periodical
- Accession number :
- edsgcl.659366978
- Full Text :
- https://doi.org/10.1503/cmaj.210132